Controversies in Targeted Therapy of Adult T Cell Leukemia/Lymphoma: ON Target or OFF Target Effects?
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Adult T cell leukemia/lymphoma (ATL) represents an ideal model for targeted therapy because of intrinsic chemo-resistance of ATL cells and the presence of two well identified targets: the HTLV-I retrovirus and the viral oncoprotein Tax. The combination of zidovudine (AZT) and interferon-alpha (IFN) has a dramatic impact on survival of ATL patients. Although the mechanism of action remains unclear, arguments in favor or against a direct antiviral effect will be discussed. Yet, most patients relapse and alternative therapies are mandatory. IFN and arsenic trioxide induce Tax proteolysis, synergize to induce apoptosis in ATL cells and cure Tax-driven ATL in mice through specific targeting of leukemia initiating cell activity. These results provide a biological basis for the clinical success of arsenic/IFN/AZT therapy in ATL patients and suggest that both extinction of viral replication (AZT) and Tax degradation (arsenic/IFN) are needed to cure ATL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170401 · Cited by 2,995
Shimoyama, M., & members of The Lymphoma Study Group (1984–87) (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08051.x · Cited by 1,608
Yoshida, M., Seiki, M., Yamaguchi, K., & Takatsuki, K. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.8.2534 · Cited by 891 · cited 1×
“Yet, ATL is characterized by the monoclonal or oligoclonal integration of HTLV-I provirus in the tumor cells [11].”
BackgroundHTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
Satou, Y., Yasunaga, J.-I., Zhao, T., Yoshida, M., Miyazato, P., Takai, K., Shimizu, K., Ohshima, K., Green, P. L., Ohkura, N., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001274 · Cited by 319 · cited 2×
“Although other viral factors can promote pathogenesis such as HBZ, tax-transgenic mice develop a disease that strikingly recapitulates human ATL [68].”
BackgroundCell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4+ T cells
Jones, K. S., Petrow-Sadowski, C., Huang, Y. K., Bertolette, D. C., & Ruscetti, F. W. (2008) · Nature Medicine · doi:10.1038/nm1745 · Cited by 284 · cited 3×
“Indeed, HTLV-1 infection of dendritic cells could provide a reservoir for HTLV-1 infection [61].”
BackgroundInfluentialTwo types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia
Tamiya, S., Matsuoka, M., Etoh, K., Watanabe, T., Kamihira, S., Yamaguchi, K., & Takatsuki, K. (1996) · Blood · doi:10.1182/blood.v88.8.3065.bloodjournal8883065 · Cited by 263 · cited 1×
“In addition, epigenetic changes in the 5′-LTR may also silence the transcription of viral genes [53–56].”
BackgroundSuzuki, T., Fujisawa, J. I., Toita, M., & Yoshida, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.610 · Cited by 256
Koiwa, T., Hamano-Usami, A., Ishida, T., Okayama, A., Yamaguchi, K., Kamihira, S., & Watanabe, T. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9389-9397.2002 · Cited by 235
Long-term study of indolent adult T-cell leukemia-lymphoma
Takasaki, Y., Iwanaga, M., Imaizumi, Y., Tawara, M., Joh, T., Kohno, T., Yamada, Y., Kamihira, S., Ikeda, S., Miyazaki, Y., et al. (2010) · Blood · doi:10.1182/blood-2009-09-242347 · Cited by 180
Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
Kannian, P., & Green, P. L. (2010) · Viruses · doi:10.3390/v2092037 · Cited by 139 · cited 1×
“Both Tax and HBZ expression is linked to different stages of HTLV-I pathogenesis [16,17].”
BackgroundPersistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence
Datta, A., Bellon, M., Sinha-Datta, U., Bazarbachi, A., Lepelletier, Y., Canioni, D., Waldmann, T. A., Hermine, O., & Nicot, C. (2006) · Blood · doi:10.1182/blood-2006-01-0067 · Cited by 139
Self-citationCurrent concepts regarding the HTLV-1 receptor complex
Ghez, D., Lepelletier, Y., Jones, K. S., Pique, C., & Hermine, O. (2010) · Retrovirology · doi:10.1186/1742-4690-7-99 · Cited by 73 · cited 1×
“The ubiquitous glucose transporter 1 and the neuropilin 1 were identified as members of the HTLV-I receptor complex [18–20].”
BackgroundSelf-citationMacchi, B., Grelli, S., Favalli, C., Mastino, A., Bonmassar, E., Faraoni, I., & Zhang, J. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-5-1007 · Cited by 66
Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-κB pathway
Kfoury, Y., Nasr, R., Hermine, O., de Thé, H., & Bazarbachi, A. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401624 · Cited by 40
Self-citation
Cited by
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report
Cook, L. B., Fuji, S., Hermine, O., Bazarbachi, A., Ramos, J. C., Ratner, L., Horwitz, S., Fields, P., Tanase, A., Bumbea, H., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.00501 · Cited by 267
Self-citationHTLV Tax: A Fascinating Multifunctional Co-Regulator of Viral and Cellular Pathways
Currer, R., Van Duyne, R., Jaworski, E., Guendel, I., Sampey, G., Das, R., Narayanan, A., & Kashanchi, F. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00406 · Cited by 156
Molecular targeting for treatment of human T-lymphotropic virus type 1 infection
Soltani, A., Hashemy, S. I., Zahedi Avval, F., Soleimani, A., Rafatpanah, H., Rezaee, S. A., Griffith, R., & Mashkani, B. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.139 · Cited by 31
In vivo antagonistic role of the Human T-Cell Leukemia Virus Type 1 regulatory proteins Tax and HBZ
Akkouche, A., Moodad, S., Hleihel, R., Skayneh, H., Chambeyron, S., El Hajj, H., & Bazarbachi, A. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009219 · Cited by 20
Self-citation
Metadata
- Authors
- Nasr, R., Hajj, H. E., Kfoury, Y., Thé, H. D., Hermine, O., & Bazarbachi, A.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2011-06-14
- Volume
- 3
- Issue
- 6
- Pages
- 750-769
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W2159293665
- Cited by
- 35
- References
- 14
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.